These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3625703)

  • 21. Inhibition of aromatase activity in the rat by aminoglutethimide and related compounds.
    Pourgholami MH; Nicholls PJ; Smith HJ; Daly MJ; Dyas J
    J Steroid Biochem; 1987 Mar; 26(3):309-12. PubMed ID: 3586648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
    Numazawa M; Oshibe M
    Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics.
    Seago A; Goss PE; Griggs LJ; Jarman M
    Biochem Pharmacol; 1986 Sep; 35(17):2911-6. PubMed ID: 3741481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships.
    Numazawa M; Oshibe M; Yamaguchi S
    Steroids; 1997; 62(8-9):595-602. PubMed ID: 9292934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
    Numazawa M; Oshibe M
    J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
    Wächter GA; Hartmann RW; Sergejew T; Grün GL; Ledergerber D
    J Med Chem; 1996 Feb; 39(4):834-41. PubMed ID: 8632407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type.
    Hartmann RW; Grün G; Bartz U; Palzer M
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):641-8. PubMed ID: 1472456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitors of aromatase. Synthesis and pharmacologic action of potential mammary tumor-inhibiting 4-alkyl-3-(4-aminophenyl)-3-ethylpiperidine-2,6-diones].
    Batzl C; Hartmann RW
    Arch Pharm (Weinheim); 1987 Jan; 320(1):51-8. PubMed ID: 3566486
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
    Abul-Hajj YJ; Liu XP; Hedge M
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
    Vanden Bossche HV; Moereels H; Koymans LM
    Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modelling study of the binding of inhibitors of aromatase to the cytochrome P-450 heme.
    Ahmed S; Davis PJ; Owen CP
    Drug Des Discov; 1996 Oct; 14(2):91-102. PubMed ID: 9010616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The inhibitory effect of miconazole on aromatase activity for androstenedione in human placental and ovarian preparations].
    Yamamoto T; Urabe M; Okada H
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1379-85. PubMed ID: 3443212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and aromatase inhibiting activity of aminoglutethimide analogs.
    Aboul-Enein HY
    Drug Des Deliv; 1988 Feb; 2(3):221-6. PubMed ID: 3255316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones.
    Hartmann RW; Batzl C
    J Med Chem; 1986 Aug; 29(8):1362-9. PubMed ID: 3735304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.
    Dowsett M; MacNeill F; Mehta A; Newton C; Haynes B; Jones A; Jarman M; Lonning P; Powles TJ; Coombes RC
    Br J Cancer; 1991 Nov; 64(5):887-94. PubMed ID: 1931611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
    Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives.
    Bayer H; Batzl C; Hartmann RW; Mannschreck A
    J Med Chem; 1991 Sep; 34(9):2685-91. PubMed ID: 1895288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.
    Lézé MP; Le Borgne M; Marchand P; Loquet D; Kogler M; Le Baut G; Palusczak A; Hartmann RW
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):549-57. PubMed ID: 15662958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs.
    Ogbunude PO; Aboul-Enein HY
    Chirality; 1994; 6(8):623-6. PubMed ID: 7857773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.